Literature DB >> 25579885

Anemia and reduced kidney function as risk factors for new onset of atrial fibrillation (from the Ibaraki prefectural health study).

DongZhu Xu1, Nobuyuki Murakoshi2, Toshimi Sairenchi3, Fujiko Irie4, Miyako Igarashi1, Akihiko Nogami5, Takuji Tomizawa6, Iwao Yamaguchi6, Kazumasa Yamagishi7, Hiroyasu Iso8, Hitoshi Ota9, Kazutaka Aonuma5.   

Abstract

Chronic kidney disease (CKD) is a potential independent risk factor for atrial fibrillation (AF). It remains unclear whether anemia is synergistically associated with increased risk of AF onset in subjects with CKD. We evaluated the association of kidney function, hemoglobin (Hb), and their combination with new-onset AF in a population-based cohort study. We conducted a 15-year prospective cohort study of 132,250 Japanese subjects aged 40 to 79 years who participated in annual health checkups from 1993. Kaplan-Meier survival analysis was used to compare freedom from new-onset AF between groups classified by estimated glomerular filtration rate grade, Hb grade, and their combination. Cox proportional hazard model analysis was used to estimate hazard ratios (HRs) for new-onset AF. During a 13.8-year mean follow-up period, 1,232 (0.93%) subjects with new-onset AF were identified. Lower estimated glomerular filtration rate and lower Hb grades were significantly associated with a higher incidence of new-onset AF. Multivariate HRs and 95% confidence intervals (CIs) of new-onset AF were 1.38 (1.21 to 1.56) for mild CKD group, 2.56 (2.09 to 3.13) for CKD group, and 1.50 (1.24 to 1.83) for anemia group. Borderline Hb level was not significantly associated with increased risk for new-onset AF (HR 1.07, CI 0.91 to 1.25, p = 0.4284). In the model with interaction term between CKD and anemia, the risk was significantly higher (p = 0.0343 for the interaction) than that predicted by each factor independently. In conclusion, decreased kidney function and lower Hb level are associated with increased risk for new-onset AF, especially when both are present.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25579885     DOI: 10.1016/j.amjcard.2014.10.041

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  20 in total

1.  Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study.

Authors:  Rupal Mehta; Xuan Cai; Alexander Hodakowski; Jungwha Lee; Mary Leonard; Ana Ricardo; Jing Chen; Lee Hamm; James Sondheimer; Mirela Dobre; Valentin David; Wei Yang; Alan Go; John W Kusek; Harold Feldman; Myles Wolf; Tamara Isakova
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-07       Impact factor: 8.237

Review 2.  Atrial fibrillation and chronic kidney disease conundrum: an update.

Authors:  Laura Tapoi; Carina Ureche; Radu Sascau; Silvia Badarau; Adrian Covic
Journal:  J Nephrol       Date:  2019-07-18       Impact factor: 3.902

Review 3.  Anemia: An Independent Predictor Of Adverse Outcomes In Older Patients With Atrial Fibrillation.

Authors:  Ali N Ali; Nandkishor V Athavale; Ahmed H Abdelhafiz
Journal:  J Atr Fibrillation       Date:  2016-04-30

4.  Matrix Metalloproteinase Neutrophil Gelatinase-Associated Lipocalin Complex Predicts Atrial Fibrillation Recurrence after Electrical Cardioversion in Obese Patients.

Authors:  Elzbieta Mlodawska; Anna Tomaszuk-Kazberuk; Paulina Lopatowska; Ewa Waszkiewicz; Hanna Bachorzewska-Gajewska; Jolanta Malyszko; Ewelina Michniewicz; Slawomir Dobrzycki; Wlodzimierz Jerzy Musial
Journal:  Cardiorenal Med       Date:  2016-08-12       Impact factor: 2.041

5.  Bidirectional Association Between Kidney Function and Atrial Fibrillation: A Population-Based Cohort Study.

Authors:  Anna C van der Burgh; Sven Geurts; M Arfan Ikram; Ewout J Hoorn; Maryam Kavousi; Layal Chaker
Journal:  J Am Heart Assoc       Date:  2022-05-17       Impact factor: 6.106

Review 6.  Management of atrial fibrillation: two decades of progress - a scientific statement from the European Cardiac Arrhythmia Society.

Authors:  Samuel Lévy; Gerhard Steinbeck; Luca Santini; Michael Nabauer; Diego Penela Maceda; Bharat K Kantharia; Sanjeev Saksena; Riccardo Cappato
Journal:  J Interv Card Electrophysiol       Date:  2022-04-13       Impact factor: 1.759

7.  eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study.

Authors:  Nisha Bansal; Leila R Zelnick; Alvaro Alonso; Emelia J Benjamin; Ian H de Boer; Rajat Deo; Ronit Katz; Bryan Kestenbaum; Jehu Mathew; Cassianne Robinson-Cohen; Mark J Sarnak; Michael G Shlipak; Nona Sotoodehnia; Bessie Young; Susan R Heckbert
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-10       Impact factor: 8.237

8.  Elevated Serum Beta-Trace Protein Levels are Associated With the Presence of Atrial Fibrillation in Hypertension Patients.

Authors:  Muhammed U Yalcin; Kadri M Gurses; Duygu Kocyigit; Sacit A Kesikli; Lale Tokgozoglu; Dicle Guc; Kudret Aytemir; Necla Ozer
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-10-05       Impact factor: 3.738

9.  Quantifying Risk Factors for Atrial Fibrillation: Retrospective Review of a Large Electronic Patient Database.

Authors:  Jaclyn Rivington; Patrick Twohig
Journal:  J Atr Fibrillation       Date:  2020-10-31

10.  Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach.

Authors:  Carmen Suárez Fernández; Suárez Fernández; Francesc Formiga; Miguel Camafort; María Cepeda Rodrigo; Jose Cepeda Rodrigo; Jesús Díez-Manglano; Antonio Pose Reino; Pose Reino; Gregorio Tiberio; Jose María Mostaza
Journal:  BMC Cardiovasc Disord       Date:  2015-11-04       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.